SEARCH

SEARCH BY CITATION

References

  • 1
    Adgent MA. Environmental tobacco smoke and sudden infant death syndrome: a review. Birth Defects Research (Part B). 2006;77:6985.
  • 2
    Andres RL, Day M-C. Perinatal complications associated with maternal tobacco use. Seminars in Fetal and Neonatal Medicine. 2000;5:23141.
  • 3
    Werler MM. Teratogen update: smoking and reproductive outcomes. Teratology. 1997;55:3828.
  • 4
    Winbo I, Serenius F, Dahlquist G, Kallen B. Maternal risk factors for cause-specific stillbirth and neonatal death. Acta Obstet Gynecol Scand. 2001;80:23544.
  • 5
    Man LX, Chang B. Maternal cigarette smoking during pregnancy increases the risk of having a child with a congenital digital anomaly. Plast Reconstr Surg. 2006;117:3018.
  • 6
    Little J, Cardy A, Munger RG. Tobacco smoking and oral clefts: a meta-analysis. Bull World Health Organ. 2004;82:21318.
  • 7
    Källen K. Maternal smoking and congenital heart defects. Eur J Epidemiol. 1999;15:7317.
  • 8
    Källen K. Maternal smoking and craniosynostosis. Teratology. 1999;60:14650.
  • 9
    Källen K. Maternal smoking and orofacial clefts. Cleft Palate Craniofac J. 1997;34:1116.
  • 10
    Källen K. Maternal smoking and urinary organ malformations. Int J Epidemiol. 1997;26:5714.
  • 11
    Wasserman CR, Shaw GM, O'Malley CD, Tolarova MM, Lammer EJ. Parental cigarette smoking and risk for congenital anomalies of the heart, neural tube or limb. Teratology. 1996;53:2617.
  • 12
    Werler MM, Sheehan JE, Mitchell AA. Association of vasoconstrictive exposures with risks of gastroschisis and small intestinal atresia. Epidemiology. 2003;14:34954.
  • 13
    Lavezzi AM, Ottaviani G, Matturri L. Adverse effects of prenatal tobacco smoke exposure on biological parameters of the developing brainstem. Neurobiol Dis. 2005;20:6017.
  • 14
    Maritz GS, Morley CJ, Harding R. Early developmental origins of impaired lung structure and function. Early Hum Dev. 2005;81:76371.
  • 15
    Källen K. Maternal smoking during pregnancy and infant head circumference at birth. Early Hum Dev. 2000;58:197204.
  • 16
    Huizink AC, Mulder EJH. Maternal smoking, drinking or cannabis use during pregnancy and neurobehavioral and cognitive functioning in human offspring. Neurosci Biobehav Rev. 2006;30:2441.
  • 17
    Källen K. The impact of maternal smoking during pregnancy on delivery outcome. Eur J Public Health. 2001;3:32933.
  • 18
    Hobbs CA, James SJ, Jernigan S, Melnyk S, Lu Y, Malik S, et al Congenital heart defects, maternal homocysteine, smoking, and the 677 C>T polymorphism in the methylenetetrahydrofolate reductase gene: evaluating gene-environment interactions. Am J Obstet Gynecol. 2006;194:21824.
  • 19
    Sasaki S, Kondo T, Sata F, Saijo Y, Katoh S, Nakajima S, et al Maternal smoking during pregnancy and genetic polymorphisms in the Ah receptor, CYP1A1 and GSTM1 affect infant birth size in Japanese subjects. Mol Hum Reprod. 2006;12:7783.
  • 20
    Shaw GM, Iovannisci DM, Yang W, Finnell RH, Carmichael SL, Cheng S, et al Endothelial nitric oxide synthase (NOS3) genetic variants, maternal smoking, vitamin use, and risk of human orofacial clefts. Am J Epidemiol. 2005;162:120714.
  • 21
    Lammer EJ, Shaw GM, Iovannisci, Finnell RH. Maternal smoking, genetic variation of glutathione S-transferases, and risk for orofacial clefts. Epidemiology. 2005;16:698701.
  • 22
    Carmichael SL, Shaw GM, Yang W, Lammer EL, Zhu H, Finnell RH. Limb deficiency defects, MSX1, and exposure to tobacco smoke. Am J Med Genet. 2004;125A:2859.
  • 23
    Carmichael SL, Shaw GM, Yang W, Laurent C, Herring A, Royle MH, et al Correlates of intake of folic acid-containing supplements among pregnant women. Am J Obstet Gynecol. 2006;194:20310.
  • 24
    Coleman PK, Reardon DC, Cougle JR. Substance use among pregnant women in the context of previous reproductive loss and desire for current pregnancy. Br J Health Psychol. 2005;10:25568.
  • 25
    Than LC, Honein MA, Watkins ML, Yoon PW, Daniel KL, Correa A. Intent to become pregnant as a predictor of exposures during pregnancy: is there a relation? J Reprod Med. 2005;50:38996.
  • 26
    Dempsey DA, Benowitz NL. Risks and benefits of nicotine to aid smoking cessation in pregnancy. Drug Saf. 2001;24:277322.
  • 27
    Benowitz NL, Dempsey DA. Pharmacotherapy for smoking cessation during pregnancy. Nicotine and Tobacco Research 2004;6:S189202.
  • 28
    U.S. Prevention Services Task Force. Counseling and interventions to prevent tobacco use and tobacco-caused disease in adults and pregnant women: U. S. Prevention Services Task Force Reaffirmation Recommendation Statement. Ann Intern Med. 2009;1505515.
  • 29
    Smoking during pregnancy – United States, 1990–2002. MMWR Surveill Summ. 2004;53:91115.
  • 30
    Ebrahim SH, Floyd RL, Merritt RK, Decoufle P, Holtzman D. Trends in pregnancy-related smoking rates in the United States, 1987–1996. JAMA. 2002;283:3616.
  • 31
    Kahn RS, Certain L, Whitaker RC. A reexamination of smoking before, during and after pregnancy. Am J Public Health. 2002;92:18018.
  • 32
    Perreira KM, Cortes KE. Race/ethnicity and nativity differences in alcohol and tobacco use during pregnancy. Am J Public Health. 2006;96:162936.
  • 33
    Yu SM, Park CH, Schwalberg RH. Factors associated with smoking cessation among US pregnant women. Matern Child Health J. 2002;6:8997.
  • 34
    Yoon PW, Rasmussen SA, Lynberg MC, Moore CA, Anderka M, Carmichael SL, et al The National Birth Defects Prevention Study. Public Health Rep. 2001;116:3240.
  • 35
    Trends in smoking before, during, and after pregnancy – Pregnancy Risk Assessment Monitoring System (PRAMS). United States, 31 Sites, 2000–2005. MMWR Surveill Summ. 2009;58:129.
  • 36
    Cnattingius S. The epidemiology of smoking during pregnancy: Smoking prevalence, maternal characteristics, and pregnancy outcomes. Nicotine and Tobacco Research. 2004;6:S12540.
  • 37
    Carmichael SL, Ahluwalia IB, and the PRAMS Working Group. Correlates of postpartum smoking relapse: results from the Pregnancy Risk Assessment Monitoring System (PRAMS). Am J Prev Med. 2000;19:1936.
  • 38
    Colman GJ, Joyce T. Trends in smoking before, during, and after pregnancy in ten states. Am J Prev Med. 2003;24:2935.
  • 39
    Nicotine replacement therapy (NRT) and other medications which aid smoking cessation: Available online at: http://www.lungusa.org. (accessed on September 27, 2009).
  • 40
    Windsor R, Oncken C, Henningfield J, Hartmann K, Edwards N. Behavioral and pharmacological treatment methods for pregnant smokers: issue for clinical practice. JAMWA. 55:30410.
  • 41
    George L, Granath F, Johansson LV, Cnattingius S. Self-reported nicotine exposure and plasma levels of cotinine in early and late pregnancy. Acta Obstet Gynecol Scand. 2006;85:13317.
  • 42
    Klebanoff MA, Levine RJ, Morris CD, Hauth JC, Sibai BM, Curet B, et al Paediatr Perinat Epidemiol. 2001;15:1403.
  • 43
    Russell TV, Crawford MA, Woodby LL. Measurement for active cigarette smoke exposure in prevalence and cessation studies: why simply asking pregnant women isn't enough. Nicotine Tob Res. 2004;6:S14151.
  • 44
    Markovic N, Ness RB, Cefilli D, Grisso JA, Stahmer S, Shaw LM. Substance use measures among women in early pregnancy. Am J Obstet Gynecol. 2000;183:62732.
  • 45
    Ford RP, Tappin DM, Schluter PJ, Wild CJ. Smoking during pregnancy: how reliable are maternal self reports in New Zealand? J Epidemiol Community Health. 1997;51:24651.
  • 46
    Cogswell ME, Bitsko RH, Anderka M, Caton AR, Feldkamp ML, Hockett Sherlock SM, et al Control Selection and Participation in an Ongoing, Population-based, Case-Control Study of Birth Defects: The National Birth Defects Prevention. Am J Epidemiol. 2009; DOI: 10.1093/aje/kwp226.